A retrospective, multicenter study of regorafenib and tipiracil/trifluridine as salvage-line therapy in patients with metatstatic colorectal cancer
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Regorafenib (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Oct 2016 New trial record